Abstract
After hitting the headlines in the 1960s, stem cell therapy has been the subject of great optimism in the treatment of many conditions.
Discoveries of new procurement methods for various stem cells has allowed the technology and research to progress to a stage where real therapeutic alter-
natives are potentially viable.
In order to determine the direction to move forward, it is first important to analyse the data that has been collected across well researched stem cell types (Embryonic Stem cells, Induced pluripotent stem cells, Haematopoetic stem cells and Mesenchymal stem cells) as well as emerging stem cell types (Very-small-embryonic-like stem cells, Spermatogonial stem cells and Parthenogenetic stem cells).
Whilst by no means conclusive, the data does support the optimism surrounding these cells. Whilst stem cells may be embraced as the future of personalised medicine, following these pilot trials, research needs to become more focussed to allow advancement.
Discoveries of new procurement methods for various stem cells has allowed the technology and research to progress to a stage where real therapeutic alter-
natives are potentially viable.
In order to determine the direction to move forward, it is first important to analyse the data that has been collected across well researched stem cell types (Embryonic Stem cells, Induced pluripotent stem cells, Haematopoetic stem cells and Mesenchymal stem cells) as well as emerging stem cell types (Very-small-embryonic-like stem cells, Spermatogonial stem cells and Parthenogenetic stem cells).
Whilst by no means conclusive, the data does support the optimism surrounding these cells. Whilst stem cells may be embraced as the future of personalised medicine, following these pilot trials, research needs to become more focussed to allow advancement.
| Original language | English |
|---|---|
| Pages (from-to) | 1-7 |
| Journal | Medical Equipment Insights |
| Volume | 5 |
| DOIs | |
| Publication status | Published - 2014 |